Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02635958 · ClinicalTrials.gov registry record
InBody Validation Study
A clinical trial, sponsored by Mayo Clinic.
- Completed
- Registry status
- 176
- Enrollment target
NCT02635958: Completed study, sponsored by Mayo Clinic.
NCT02635958 is a clinical trial that has completed, run by Mayo Clinic. The registered enrollment target is 176 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02635958 has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 176 participants
- Enrollment target
Study Summary
With, one in three Americans now having a body mass index (BMI) greater than 30, and the fastest growing segment of the population having a BMI greater than 40, it is paramount to conduct validation of approaches to measure body composition. Currently the dual-energy x-ray absorptiometry (iDXA) is the gold standard for measuring the body composition. But it is often difficult to perform since it is limited to specific height, weight and BMI's. InBody is a tool which uses bio electric impedance to measure the body composition. This study will compare both approaches. Validation is necessary as it is clinically quite pertinent to accurately assess a patients' body fat percentage, fat free mass, and total body water and changes that are occurring with nutritional support.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 176 participants |
| Start Date | 2015-12 |
| Est. Completion | 2019-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02635958
The ClinicalTrials.gov registry entry for NCT02635958 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 176 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02635958 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02635958 about?
NCT02635958 is a clinical study titled "InBody Validation Study". With, one in three Americans now having a body mass index (BMI) greater than 30, and the fastest growing segment of the population having a BMI greater than 40, it is paramount to conduct validation of approaches to measure body composition. Currently the dual-energy x-ray absorptiometry (iDXA) is t...
What is the current status of trial NCT02635958?
This trial is currently completed. The enrollment target is 176 participants. The study started on 2015-12. Estimated completion is 2019-12.
Who is sponsoring clinical trial NCT02635958?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.